Andere Sprachen GSK plc

Aktien

A3DMB5

GB00BN7SWP63

GSK

Pharmazeutika

Markt geschlossen - London S.E. 17:35:00 12.01.2026 % 5 Tage Veränd. 1. Jan.
1.877,00 GBX -0,48 % Intraday Chart für GSK plc +3,10 % +2,88 %

Andere Sprachen

12.01. Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026
12.01. Haisco Pharmaceutical Group Co., Ltd. Enters into an Exclusive Licensing Agreement with AirNexis
12.01. Summit Therapeutics, GSK Team up on Clinical Trial for Combination Cancer Therapy
09.01. Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
09.01. AnaptysBio Moves to Dismiss GSK's Tesaro Lawsuit Over Jemperli Royalty Dispute
09.01. Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026
09.01. UK Stocks-Factors to watch on January 9
09.01. Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices
09.01. AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty
09.01. AnaptysBio Files to Dismiss Tesaro's Claim it Breached Royalties Contract
09.01. Anaptys files motion to dismiss Tesaro's claim of anticipatory breach of contract in ongoing litigation
08.01. Praxis Precision Medicines, Inc. Announces Management Changes
08.01. GSK plc Appoints Luke Victor Miels as Director, Effective January 1, 2026
07.01. European Stocks Close Mixed in Wednesday Trading; Euro Area Inflation Declines in December
07.01. Les indices européens divergent après les statistiques sur l'emploi américain
07.01. Alert wrongly tagged to Helix Resources withdrawn
07.01. Helix announces multi-year strategic collaboration with GSK
07.01. GSK : La valeur du jour en Europe GSK recule, pénalisé par Barclays
07.01. Helix announces multi-year strategic collaboration with GSK to drive precision medicine development
07.01. GSK plc Announces the European Commission's Approval of Shingrix in Prefilled Syringe
07.01. GSK plc Announces Positive Topline Results from B-Well 1 and B-Well 2 Phase 3 Studies for Bepirovirsen
07.01. GSK plc Announces Positive Results from Two Pivotal Phase 3 Studies, B-Well 1 and B-Well 2, Evaluating the Safety and Efficacy of bepirovirsen
07.01. Pas de tendance claire en Europe avant l'enquête ADP sur l'emploi aux Etats-Unis
07.01. Berenberg raises Vodafone; Barclays cuts Hikma
07.01. GSK a reçu une approbation de l'UE pour son vaccin contre le zona
Keine Ergebnisse zu dieser Suche